Chan, Albert W <br/><br/>
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting.  [electronic resource] 

 -  The American journal of cardiology  Mar 2005 
 - 791-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2004.11.041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Balloon Occlusion--instrumentation<br/>Carotid Stenosis--surgery<br/>Cerebral Hemorrhage--mortality<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Endarterectomy, Carotid<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Intracranial Embolism--mortality<br/>Male<br/>Middle Aged<br/>Neurologic Examination--drug effects<br/>Outcome and Process Assessment, Health Care<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Postoperative Complications--mortality<br/>Prostheses and Implants<br/>Stents